Regulus Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q3 2011 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Regulus Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2011 to Q3 2024.
Regulus Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.2M, a 87.2% decline year-over-year.
Regulus Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$44.6M, a 49.9% decline year-over-year.
Regulus Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$31.1M, a 10.2% decline from 2022.
Regulus Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$28.2M, a 1.52% decline from 2021.
Regulus Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$27.8M, a 96.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$44.6M	-$15.2M	-$7.09M	-87.2%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	-$37.5M	-$12.3M	-$4.95M	-67.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$32.6M	-$8.83M	-$1.46M	-19.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$31.1M	-$8.3M	-$1.37M	-19.7%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-21
Q3 2023	-$29.7M	-$8.13M	-$562K	-7.43%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	-$29.2M	-$7.32M	-$140K	-1.95%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$29M	-$7.37M	-$800K	-12.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$28.2M	-$6.93M	+$29K	+0.42%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-21
Q3 2022	-$28.3M	-$7.56M	+$856K	+10.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$29.1M	-$7.18M	-$537K	-8.09%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	-$28.6M	-$6.57M	-$771K	-13.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$27.8M	-$6.96M	-$5.93M	-576%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-23
Q3 2021	-$21.9M	-$8.42M	-$7.32M	-669%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$14.6M	-$6.64M	-$142K	-2.19%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$14.4M	-$5.8M	-$263K	-4.75%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-13
Q4 2020	-$14.2M	-$1.03M	+$3.41M	+76.8%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-11
Q3 2020	-$17.6M	-$1.1M	+$3.9M	+78.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$21.5M	-$6.5M	-$1.83M	-39.2%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-10
Q1 2020	-$19.6M	-$5.54M	-$2.8M	-102%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	-$16.8M	-$4.44M	+$3.55M	+44.4%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-09
Q3 2019	-$20.4M	-$4.99M	+$4.86M	+49.3%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$25.2M	-$4.67M	+$8.68M	+65%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$33.9M	-$2.74M	+$12.8M	+82.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q4 2018	-$46.8M	-$7.98M	+$5.72M	+41.8%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-12
Q3 2018	-$52.5M	-$9.85M	+$5.56M	+36.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$58M	-$13.3M	+$7.97M	+37.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$66M	-$15.6M	+$4.11M	+20.9%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	-$70.1M	-$13.7M	+$6.04M	+30.6%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-18
Q3 2017	-$76.2M	-$15.4M	+$3.78M	+19.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-09
Q2 2017	-$79.9M	-$21.3M	-$129K	-0.61%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$79.8M	-$19.7M	+$1.69M	+7.88%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-10
Q4 2016	-$81.5M	-$19.7M	-$12.4M	-168%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-18
Q3 2016	-$69.1M	-$19.2M	-$5.85M	-43.8%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016	-$63.3M	-$21.2M	-$7K	-0.03%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-02
Q1 2016	-$63.3M	-$21.4M	-$8.51M	-66.1%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-05
Q4 2015	-$54.8M	-$7.36M	+$2.17M	+22.8%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-08
Q3 2015	-$56.9M	-$13.3M	-$1.69M	-14.5%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-02
Q2 2015	-$55.2M	-$21.2M	-$8.17M	-62.8%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-03
Q1 2015	-$47.1M	-$12.9M	-$2.17M	-20.2%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-03
Q4 2014	-$44.9M	-$9.53M	-$4.87M	-105%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-03
Q3 2014	-$40M	-$11.7M	-$8.75M	-301%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-06
Q2 2014	-$31.3M	-$13M	-$8.33M	-178%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-05
Q1 2014	-$23M	-$10.7M	-$5.16M	-92.9%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-08
Q4 2013	-$17.8M	-$4.66M	-$357K	-8.3%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-23
Q3 2013	-$17.4M	-$2.91M	+$627K	+17.8%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-06
Q2 2013	-$18.1M	-$4.69M	-$2.13M	-83.2%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013	-$15.9M	-$5.55M	-$3.37M	-155%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-09
Q4 2012	-$12.6M	-$4.3M			Oct 1, 2012	Dec 31, 2012	10-K	2015-02-19
Q3 2012		-$3.53M	-$2.56M	-263%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-14
Q2 2012		-$2.56M			Apr 1, 2012	Jun 30, 2012	10-Q/A	2013-08-16
Q1 2012		-$2.18M			Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-15
Q3 2011		-$973K			Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.